The Company expects revenue in the range of $235M to $245 M in fiscal year 2025, up from the original guidance of $200 M to $210M, consensus $238.49M…Sees FY25 adjusted EBITDA of $21M to $24M up from $18M to $21M and adjusted earnings per share in the range of 72c to 88c, up from 70c to 80c. The Company expects a full year tax rate of approximately 22% to 24%. This guidance reflects the current trends in the business. The Company’s guidance for adjusted non-GAAP EBITDA and adjusted non-GAAP earnings per diluted share excludes any non-operating or non-recurring expenses that may materialize during fiscal 2025. The Company is not providing guidance for GAAP earnings per diluted share for fiscal 2025 due to the potential occurrence of one or more non-operating, one-time expenses, which the Company does not believe it can reliably predict.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFVN:
- LifeVantage reports Q2 EPS 22c, consensus 13c
- LifeVantage management to meet virtually with Craig-Hallum
- LifeVantage announces completion of international in vitro study on MB System
- LFVN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- LifeVantage appoints Thompson as Chief Information, Innovation Officer